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Introduction
Erectile dysfunction (ED) affects one out of two American men over the age of 50
and is linked to prevalent medical conditions such as cardiovascular disease and
diabetes. Approximately one third of men with ED will fail conservative treatments and
around 25,000 patients choose to undergo penile prosthesis (PP) implantation annually.1
While infrequent, infection is a devastating complication occurring in approximately 3% of
primary and up to 18% of revision surgeries.2 The risk for infection exists peri-operatively
and also endures long-term with approximately 500,000-750,000 patients at risk at this
present time. Infections may be severe or subtle, presenting as chronic pain or implant
migration. Unfortunately, the majority of these patients will require a combination of
systemic antibiotic treatment and device removal. Such treatment results in significant
economic burden to the health system and physical, psychological, and financial burden
to the patient. Improved prevention strategies are needed to reduce PP infection (PPI).
Literature suggests that infection prevention strategies amongst urologists
performing PP operations vary in many aspects, including the duration of skin preparation
and multiple aspects of antibiotic administration.3 This may be due in part to the fact that
75% of PP surgeries are done by urologists who perform  4 surgeries/year, while the top
20 highest volume urologists perform 17% of the total volume.4 Based on surgical
outcome studies, low operation volume may be associated with worse outcomes, and low
volume physicians and hospitals can learn from those with greater experience5. These
findings support the need for best practices recommendations for PP surgery. The aim of
this review is to broaden the discussion of best practices by not only examining practices
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in urology, but additionally to delve into the field of orthopaedic surgery to identify
techniques and approaches that may be applied to PP surgery.

Biofilm Formation
Upon implantation, biomaterials, which are often inert, are rapidly coated by
extracellular matrix molecules (ECM), and provoke a foreign body reaction that induces
fibrous encapsulation and causes attenuation of immune surveillance—all conditions
ideal for bacterial and fungal biofilm formation (Figure 1).6 These adherent bacteria
become antibiotic tolerant and can progress to form biofilms (i.e., communities of
adherent bacteria encased by a polysaccharide coating). Generally, biofilms progress
through surface attachment, cell proliferation and, film maturation, to detachment and
spread.7
During biofilm maturation, cells also undergo phenotypic changes, becoming less
metabolically active and needing fewer nutrients—so called sessile bacteria. The biofilm
matrix, largely consisting of polysaccharides and proteins, provides isolation and security
from mechanical forces and the body’s immune system, and the phenotypic changes
make the organisms more drug resistant. For example, many commonly used antibiotics
attack bacterial cell wall production or protein synthesis, functions that are critical for rapid
growth, but less important in a more dormant phenotype. As a result, antibiotic
concentrations more than 1000 times that needed to inhibit growth (minimum inhibitory
concentration, MIC) of the unadhered (planktonic) bacteria may be needed to combat
biofilms.7
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Biofilms pose a particular challenge when considering the increased infection rates
after revision surgeries of PPs. One theory suggests that an initial biofilm is formed after
primary surgery, which remains clinically silent until disrupted during the revision surgery.2
A study by Henry et al. revealed that 70% of the non-antibiotic coated PPs had culture
positive bacteria at the time of revision surgery due to non-infectious causes, of which
90% were Staphyloccoccus species.8 Another study by Silverstein et al. found that
implants contained evidence of biofilm formation in 8 out of 10 patients undergoing
revisions due to non-infectious causes.9 The orthopaedic field has similar findings.
Particularly, large numbers of shoulder implant surgeries appear to harbor bacteria
without manifesting signs of infection. Efforts to decrease biofilm formation could
therefore decrease the infection risk after revision surgery.10,11

Perioperative Measures to Decrease Surgical Site Infection (SSI)
Appropriate patient selection and optimization of patient related factors are
important aspects of reducing SSI that are recognized and will not be covered in depth in
this article. While there are not universally accepted approaches to patient related factors
for PP surgery, even from an international consultation on sexual medicine,5 the following
can be considered to minimize infection risk based on the orthopaedic literature:
temporarily stopping immunosuppressive drugs (e.g. anti-rheumatic drugs),12 having the
HbA1c level below 7.7%,13 having a body mass index of less than 40 kg/m 2, not being
malnourished (can be assessed by having normal serum albumin and transferrin levels
and total lymphocyte counts), and abstaining from alcohol consumption and smoking for
at least a period of four to eight weeks12. Perioperative measures are crucial in fighting
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the risk of infection, since most PP infections result from perioperative contamination from
skin flora. Late implant infection is thought to be in part due to hematogenous spread from
a remote infection.6
Many surgical fields struggle with biofilm formation and SSI. Prosthetic joint
infections (PJI), which arise after joint replacements, are another important problem, and
treatment methods have been reviewed by orthopaedic surgeons and infectious disease
specialists at the International Consensus Meetings (ICM) in 2014 and 2018.14 This
collaboration serves as a model for the type of collective approach that may help to further
improve prevention across surgical specialties. A summary of current perioperative
measures in PP and orthopaedic surgeries is provided in Table 1.

Pre-Existing Infection Control
The American Urological Association (AUA) ED Guidelines recommend that PP
surgery should not be conducted “in the presence of systemic, cutaneous, or urinary tract
infection”.15 In the case of pre-existing infection, surgery should only be performed once
a course of antibiotics has been completed and symptoms have subsided. These
recommendations are shared within surgical fields, including orthopaedic surgery. If the
patient has an active skin infection, the lesions should be treated before (elective) joint
replacement surgery.16 Specifically, many SSIs originate from surgically-mobilized
pathogens that are considered endogenous skin flora. Likewise, any potential source of
transient bacteremia, such as dental procedures and symptomatic urinary tract infections,
should be resolved before surgery.16 In a retrospective study of 2,349 surgeries, patients
with remote skin infections were three times more likely to have a SSI (21% with skin
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infection vs. 7% without). Another prospective observational study with 9,245 patients
undergoing joint replacement identified urinary infection as an independent predisposing
factor for PJI (odds ratio=5.45, p=0.04).17
Finally, being a methicillin-resistant Staphylococcus aureus (MRSA) carrier (i.e.,
colonized, but not actively infected) is a major risk for infection. In a retrospective cohort
study of 9,863 surgical procedures, patients whose nares were colonized with MRSA
were 9 times more likely to have a SSI due to MRSA.18 For orthopaedic surgeries,
preoperative nasal screening is not common, but Rao et al. found S. aureus screening
before total joint arthroplasty, followed by decolonization with mupirocin ointment to the
nares twice daily and chlorhexidine baths once daily for 5 days prior to the operation
decreased infection rates from 2.6% to 1.5%).19

Antibiotic Prophylaxis
The AUA Urologic Procedures and Antimicrobial Prophylaxis Best Practice
Statements indicate antibiotic prophylaxis should be started 1-2 hours before surgery20,
cover skin flora, and last perioperatively (postoperative administration is not
recommended unless there is evidence for infection).5 Orthopaedic recommendations are
similar, but with additional suggestions about local antibiotics and special circumstances.
Extended antibiotic prophylaxis in the absence of infectious symptoms is discouraged,
due to increased risk of resistance. This is contrary to commonly performed postoperative
antibiotic administration after PP surgery, despite lack of data to support its use. An
exception may be made for patients at an increased risk of infection, for example those
undergoing revision surgeries. However, a recent study demonstrated that rates of
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explantation due to PPI did not significantly vary between patients without risk factors with
no postoperative antibiotics, patients with risk factors with no antibiotics, and patients with
risk factors who did receive antibiotics (0% vs 4% vs 5%, p=0.13).21
Prophylaxis with a first-generation cephalosporin is common for those undergoing
orthopaedic surgical procedures; for MRSA colonized patients (as well as those with
cephalosporin allergies), vancomycin or teicoplanin is given. Local supplementation with
vancomycin powder is frequently used in spinal and cardiothoracic/vascular surgery.
While there is data to claim that vancomycin powder decreases SSI in the spine, a metaanalysis found that its protective effect only occurred in the presence of spinal implants
(p=0.023), and was not significant without an implant (p=0.226).22 The results remain
controversial as a randomized, controlled trial did not find an effect, albeit, reaching
significance is difficult given the low incidence of SSIs—a ubiquitous problem with implant
infection research.23 In addition, antibiotic-loaded calcium sulfate/phosphate carriers have
not been proven to decrease the risk of SSI/PJI and all antimicrobial prophylaxis carries
the concern that antimicrobial resistance may be fostered.24

Surgical Site Preparation
It has long been known that preoperative antiseptic washes decrease skin microbial
counts. Preoperative bathing or scrubbing by the patient is largely left to the internal
protocols of surgical centers.1 However, some recommend using a chlorhexidine-based
soap twice daily for at least a week before surgery.25 In orthopaedic surgery, it is
recommended that patients start cleansing at home with chlorhexidine gluconate and the
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ICM on PJI and Centers for Disease Control (CDC) support whole-body cleansing at least
24 hours pre-operatively.12
Immediately before surgery, chlorhexidine-alcohol was more effective than
povidone-iodine in clearing the skin flora at the incision site during genitourinary prosthetic
surgery; 8% of chlorhexidine-alcohol patients’ cultures were positive, while 32% were
positive for the povidone-iodine group (p=0.0091).26 The choice of skin preparation agent
does not appear to matter as long as isopropyl alcohol is included in the solution. This
suggestion is based on, among others, the systematic review by Maiwald and Chan,
which found that the chlorhexidine-alcohol combination was superior to aqueous
competitors, but comparable to other combinations with alcohol.27
For PP surgery, an ideal time to remove hair has not been defined; however, clipping
or use of depilatory creams resulted in fewer SSIs than shaving.10 One timing
recommendation for hair removal via clipping has been immediately before the operation.
The orthopaedic surgery recommendations likewise state that hair removal at the site of
incision is not necessary if it will not interfere with the operation. However, it is suggested
when necessary that hair be removed with clippers or depilatory creams immediately
before the surgery outside the operating room (OR).28 A meta-analysis of hair removal for
surgeries found that there were no differences in the number of SSIs between hair
removal techniques and no hair removal, except shaving which resulted in higher SSIs
than all other options, including no hair removal.29

OR Environment
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OR environment may have an effect on SSI risk, and orthopaedic surgeons have
recommended strategies such as keeping the OR traffic and personnel to a minimum,
which reduces SSI risks associated with high levels of airborne microorganisms in the
OR. A Swedish study showed strong correlation (r=0.74, p=0.001) between total colonyforming units (CFU)/m3 and total traffic flow during orthopaedic trauma implant surgery.30
Other factors are related to surgical technique, such as suggested replacement of suction
tips every 60 minutes, similar to recommendations about gloves, as both acquire bacterial
contamination over time. Possible causes of contamination include the large amount of
air and fluids passing through the suction tip, direct contact with the patient’s skin, or
improper technique by operating team members. Importantly, despite the low overall
infection rates, one study showed suction tip bacterial contamination in 54% of evaluated
surgeries.31 The contamination was less frequent for procedures lasting less than one
hour (9.1%) compared to longer procedures (66.7%), again highlighting the risk of longer
operative times. These recommendations could be more widely adopted despite a lack
of specific studies examining the OR environment in PP surgery.

Antibiotic-coated implants
A powerful way to mitigate PPIs is to modify the device to prevent biofilm formation
and infection. Boston Scientific (formerly American Medical Systems) developed a
rifampin and minocycline coated implant in 2001, while Coloplast (formerly Mentor)
developed a hydrophilic coated implant (in 2002) that allowed for individualized antibiotic
coating at the time of surgery. Both device modifications decreased PPIs in both primary
and revision surgery.32 For example, Eid et al. found that both brands of coated implants
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decreased the infection rate from 5.3% to 2%.33 In 2013, a group of experts on PPs
unanimously recommended the use of devices that carried antimicrobial surface
modifications.1 Antimicrobial orthopaedic implants have explored tethering, coating, and
loading, with a few silver coated implants used clinically, and the rest showing promise in
pre-clinical and in vitro studies.6

Surgical Technique
Infection risk does not appear to correlate with surgical approach of PP placement
(e.g., penoscrotal or infrapubic),20,5 but a ‘no touch’ technique for the operation resulted
in decreased infection rates with combinations of this technique and antibiotic-coated
implants brought rates to as low as 0.46%.33 Another group achieved an infection rate of
1.5% with a less time- and effort-intensive ‘modified no touch’ technique.34,20
Comparable to the ‘no touch’ technique, scalpel replacement is recommended after
the initial incision in orthopaedic surgeries. Similarly, it is recommended that surgeons
change gloves after draping, before working with implants, and whenever gloves are
visibly perforated, with some even recommending that gloves be changed at least once
every 60 to 90 minutes. Ward et al. demonstrated the benefit of changing gloves; in a
randomized trial, changing outer gloves (while double-gloving) 1 hour into an orthopaedic
procedure significantly decreased contamination of the gloves (13% vs 23%, p<0.05).35
There are no current recommendations for or against changing the gown. Using a
bacterial strike-through study, Ward et al. also found that paper gowns had less bacterial
transmission than cloth ones in the laboratory setting (26/27 cloth gowns vs. 0/27 paper
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gowns, p<0.001), and recommended that disposable paper gowns be used for all
surgeries, especially those using implants.35
In terms of wound closure, use of certain materials or specific techniques does not
seem to affect SSI rates. For example, the antibacterial-coated sutures that decrease the
risk of SSI after colorectal surgery have not proven to be as effective in orthopaedic
surgeries.36 In vitro studies have suggested that barbed sutures in aseptic surgery and
monofilament sutures in septic surgery may be preferable; however, these suggestions
are based on bacterial presence and not on other properties such as mechanical strength,
which also need to be considered.37 Prophylactic vacuum-assisted incisional dressings
are only recommended for patients who are at increased risk. Surgical suction drains do
not appear to influence the risk of SSI in PP or orthopaedic surgeries.38 Occlusive and/or
silver-impregnated dressings are recommended for routine use instead of standard
gauze. A meta-analysis shows that occlusive dressings are associated with lower rate of
wound complications; for example, hydrofiber dressings were less likely to have wound
complications, such as blister and erythema, than standard passive dressings (odds
ratio=0.28).39 Once the dressing is applied, wound coverage for a minimum of 48 hours
is recommended unless there is substantial drainage, and the incision site should stay
dry during this interval.36 A Mummy-wrap has been suggested as a penile-scrotal
compressive dressing to decrease swelling and promote healing 24-48 hours after PP
surgery; however, no further concrete wound recommendations exist at this time.34

Irrigation
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Based on CDC and World Health Organization (WHO) guidelines, surgical site
irrigation with dilute betadine has been considered optimal in orthopaedic surgery.
Betadine contains povidone-iodine, which achieves antisepsis by becoming toxic to
microorganisms through the release of free iodine.40 However, while some studies have
shown decreased incidence of PJI following betadine lavage, the effectiveness of this
practice has recently been called into question.41 Additionally, WHO and the National
Institute for Health and Care Excellence recommend against the inclusion of antibiotics
within the lavage solution, as this may increase antibiotic resistance and has been shown
to be less effective than povidone-iodine.40 The pressure of the irrigation solution does
not seem to influence infection rates, suggesting that low pressure lavage with povidoneiodine is a cost-effective means for irrigation in PP operations. However, implementation
of irrigation in the primary PP operation protocol can be challenging as the technique
must not disrupt the antibiotic coating layer found in most PPs. Irrigation may best be
employed before placing the implant, or after an initial layer of tissue is closed over the
device and prior to closing the skin.

Washout
Studies have shown that washout after the removal of the first PP (for noninfectious causes) decreases the risk of infection after revision.10 As stated before,
revision surgeries have a much greater risk of infection compared to primary surgeries.
Such infections are hypothesized to originate from the biofilm that occurs after the primary
surgery. Washout may help remove any remaining bacteria in spaces around the PP
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implant. While a washout is recommended, no data suggests which solution(s) may be
best.10,11

Treatments for Implant infection
Diagnosis
A standard protocol for evaluating PPI does not exist; however common approaches
may include swab of draining fluid, needle aspiration of fluid, computed tomography or
ultrasound imaging, serum testing (complete blood count/C-reactive protein/erythrocyte
sedimentation rate), and wound/tissue/device culture in the OR. A multi-institutional study
evaluating clinically infected PP explantations have reported device cultures showing no
growth or non-specific growth in up to 33% of cases.42 In orthopaedic surgery, the use of
intraoperative Gram stain is an unreliable test to diagnose PJI. Likewise, swab cultures
have weak diagnostic accuracy. Intraoperative tissue cultures (3-5 samples) and synovial
fluid, on the other hand, should be collected. A study dedicated to finding the number of
cultures needed for pathogen identification found the optimal number of cultures needed
for a positive result was 4 in joint replacement surgeries.43

Antibiotic therapy
In the case of active infection, after surgical removal and replacement of a PP, it is
recommended to use systemic antibiotics based on culture results from the infection site.1
Similarly, in the case of PJI, the antimicrobial therapy should be determined based on the
organisms present in the joint space. When choosing antimicrobials, biofilm formation
should be taken into account, especially in debridement and implant retention (DAIR)
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procedures. For both orthopaedic and urologic surgeries, future studies may reveal novel,
more reliable methods of local antibiotic administration.

Salvage Surgery & Irrigation
The Mulcahy’s salvage technique was introduced as a method to remove and
replace an infected PP during the same setting to minimize the development of corporal
fibrosis, loss of penile length, and challenging repeat surgery that may result with device
removal alone.44 A series of antiseptic solutions are used to aggressively irrigate the
tissue bed to mechanically remove the biofilm followed by further washing with
antimicrobials in the hopes of eradicating remaining bacteria; however, there is no
agreement on which solutions should be utilized.1
There are several classification systems for PJIs; the one proposed by Segawa et
al. is based on the clinical presentation.45 Type-I, II, III and IV infections are defined as
clinically silent infections associated with positive cultures at revision surgery, early
postoperative infections (within one month), (late) acute hematogenous infections, and
late chronic and typically indolent infections, respectively.45,46 The management
strategies for each type of infection are very involved and include: for Type-I infections,
the revision includes DAIR with replacement of the modular components (i.e.,
polyethylene, liners), similar to one-stage reimplantation, followed by parenteral antibiotic
course for 4-6 weeks, which may be extended to oral antibiotic therapy. 47 Type-II
infections should undergo surgical debridement and component retention, followed by
parenteral antibiotics for 4-6 weeks, which may again be followed by oral antibiotics. For
Type-III infections, if the symptoms have been present <3 weeks, the implant is well fixed
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and the patient is immunocompetent, the salvage strategy consists of debridement,
component retention, and parenteral antibiotics. However, biofilms or microbes may still
be present on the retained implant components, and taken together with patient comorbidities, literature on DAIR shows a variable success rate (20-100%).48 Finally, for
Type-IV infections, a one- or two-stage reimplantation strategy is recommended, with
resection of the implant, debridement, and a 4-6 week parenteral antibiotic course. The
two-stage

reimplantation

surgery

involves

using

an

antibiotic-eluting

polymethylmethacrylate static or articulating spacer that occupies the implant space for
six weeks or more, after which a new implant is placed.46 Literature on this procedure
suggests success rates as high as 80%, but warn of increased surgical time, cost, and
morbidity.47 Overall, most PJIs require a combination of surgical debridement and
parenteral and/or oral antibiotic therapy with either retention or replacement of the
implant.

Multidisciplinary Approach
Due to the complexity of PJI case management, it is recommended that those cases
be referred to a tertiary care center.49 Revision surgeries due to infection were found to
have longer operative time with more complications than revision surgeries in a study of
hip replacements (p<0.02).50 Other outcomes such as number of hospitalizations,
outpatient visits, and hospital costs were higher for revisions due to infection (p<0.001).
At tertiary health centers, patients have access to multidisciplinary healthcare teams
consisting of infectious disease specialists, pharmacists, and more. Such teams following
well-established care protocols seem to yield the best results in management.49 Referring
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PPI cases to tertiary care centers may also be beneficial. The summary of treatment
strategies in PP and orthopaedic surgeries can be found in Table 2.

Discussion
The field of PP surgery has seen considerable advancements over the last 20
years.2,10 For PPI in particular, there has been a multifaceted approach to preventing
infection. While these measures have helped, PPI remains a clinically-significant problem.
Part of the challenge may be due to the lack of an unified infection prevention protocol
among urologists and the fact that the majority of PP are placed by surgeons who perform
this surgery relatively infrequently.4 This is in contrast to fields like orthopaedic surgery,
where surgeons perform implant surgeries at higher volumes and each surgeon tends to
specialize in certain procedures (e.g. hip vs shoulder).11
In the fight against implant infections, it is critical to remember that not all responsible
organisms are equally susceptible to preventative measures. Recent advances, such as
antibiotic-coated PPs and alcohol-based skin antiseptics, have had a substantial impact
on decreasing the overall rate of infection with a particular effect on Staphylococcal
species, which is historically the most common infection organism. However, this also
means that the relative prevalence of other organisms such as fungi and Gram-negative
bacteria such as Escherichia coli have increased, in cases of both overt infection and
clinically uninfected biofilms. This changing profile of responsible organisms must be
taken into consideration, while planning novel strategies of infection prevention and
treatment, especially because these organisms result in sicker patient scenarios.2
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In this review, we have highlighted several measures that can be applied to ED
surgeries by urologists to decrease the risk for SSI based on the orthopaedic literature.
We refer to Tables 1 and 2 for an overview of perioperative measures in ED surgery and
orthopaedic surgery. In summary, urologists may benefit from additional measures
including nasal screening for MRSA and treating positive cases preoperatively. Extended
antibiotic prophylaxis without evidence of infection should be avoided. In the perioperative
time period, the surgical site should be prepared with an alcohol-based solution and, if
hair removal is required, shaving should be avoided. In the OR, traffic, number of
personnel, and operation length should be kept to a minimum. Gloves and suction tips
may be changed every hour as well as when contamination occurs. Irrigation should be
applied carefully and not disrupt the antibiotic coating on implants, if present. After surgery
is complete, occlusive dressings are recommended instead of standard gauze. In the
event of a postoperative infection, tissue cultures with 3-5 samples may be required for
an accurate diagnosis. A multidisciplinary healthcare team may be best equipped to treat
patients with SSIs.
In conclusion, while the advent of antimicrobial-coated PPs as well as other
preventative measures have considerably decreased the risk of PPIs, the remaining
infections require a reevaluation of practice protocols and creative thinking to find
appropriate solutions. The most practical, cost-effective and patient-friendly method of
infection control is preventing infections or even the establishment of biofilms that carry
the risk of future infections. As research continues to investigate even better antimicrobial
coatings and antiseptic washing regimens, we hope that reviewing orthopaedic surgery
practices can serve to strengthen the fight against PPIs.
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Figure 1: Schematic representation of biofilm development in penile implants. In the inset,
scanning electron microscope image of Staphylococcus aureus biofilm on polylactic acid
disc in vitro; biofilm forms in surface irregularities and propagates outward, as would be
seen in the connection points between the reservoir and tubing

Table 1: Summary of perioperative infection control measures, in chronological order of
consideration during the surgical timeline

Table 2: Summary of treatments for implant infection, in chronological order of
consideration during the treatment and surgical timeline
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